The Limited Times

Now you can see non-English news...

New challenges in the distribution of medicines in France

2020-02-23T21:45:11.278Z


INFOGRAPHY - The market is shaken by new players, accused of contributing to supply disruptions.


"It's the drop of water that makes the vase overflow!" The delegate of the Pharmaceutical Distribution Union Chamber, Emmanuel Dechin, is upwind. This profession - which buys drugs from pharmaceutical laboratories, stores them and then resells them to 21,000 pharmacies in France - has seen its market share erode in recent years. The fault of particular wholesalers-distributors, the “short liners”. There are only about thirty of them, most of them SMEs, in a sector dominated by seven French or international heavyweights (OCP, Alliance Healthcare, Phenix, Cerp, etc.). Their weight remains modest - short liners hold 6.2% of the market in volume and less than 3% in value - but it has almost doubled since 2009, according to the Court of Auditors.

Read also: A race against the clock to deliver pharmacies in two hours flat

These actors take advantage of the legal vagueness to circumvent the public service obligations of the profession, namely to reference 9/10 of prescription drugs or to deliver French pharmacies in priority. For two years,

This article is for subscribers only. You still have 81% to discover.

Subscribe: € 1 for 2 months

cancellable at any time

Enter your email

Already subscribed? Login

Source: lefigaro

All business articles on 2020-02-23

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.